Atıf İçin Kopyala
Inal A., Kos F. T., Algin E., Yildiz R., Berk V., ÜNEK İ. T., ...Daha Fazla
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.19, sa.2, ss.125-129, 2015 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
19
Sayı:
2
-
Basım Tarihi:
2015
-
Doi Numarası:
10.5114/wo.2014.43933
-
Dergi Adı:
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus
-
Sayfa Sayıları:
ss.125-129
-
Anahtar Kelimeler:
pancreatic cancer, gemcitabine-refractory, patients, prognostic factors
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
Aim of the study: Systemic chemotherapy for patients with pancreatic cancer has limited impact on overall survival (OS). Patients eligible for chemotherapy should be selected carefully. The aim of the study was to search for prognostic factors for survival in patients with gemcitabine (Gem)-refractory or with gemcitabine and cisplatin (GemCis)-refractory advanced pancreatic cancer.